Company Number: 13331991

Analysis Date: 2025-07-19 13:06 UTC

1. Risk Rating: LOW
   CUR8 Earth Limited demonstrates a strong liquidity position with substantial cash holdings and net current assets significantly exceeding current liabilities. The company is active, compliant with filing deadlines, and shows a notable increase in shareholders' funds largely driven by share premium. No indications of regulatory or governance issues are apparent from the provided data.

2. Key Concerns:

• Profit and Loss Reserve Deficit: The company has a negative retained earnings figure (-£1,127,602), which may indicate accumulated losses that should be monitored for future profitability and sustainability.
• Limited Historical Financial Data: Being a relatively new company (incorporated 2021), the financial history is short, limiting the ability to assess long-term operational stability.
• Concentration of Control: One individual (Dr Anne Gabrielle Walker) holds 75-100% ownership and voting rights, which may pose governance risk related to decision-making concentration.

3. Positive Indicators:

• Strong Liquidity: Cash balances of £4.68 million and net current assets of over £4.2 million at the latest year-end indicate excellent capacity to meet short-term obligations.
• Solvency: Net assets increased substantially to over £4.2 million, supported by a large share premium account indicating recent capital injections.
• Compliance: The company is current with its annual accounts and confirmation statement filings, showing no overdue submissions or penalties.
• Industry Focus: Operating in the business and domestic software development sector (SIC 62012) with an environmental consulting activity focus indicates alignment with growing market trends.

4. Due Diligence Notes:

• Investigate the nature and sustainability of accumulated losses reflected in the negative profit and loss account, including management plans for returning to profitability.
• Review the source and terms of the significant share premium, including whether capital injections are ongoing or one-off.
• Examine related party transactions or governance controls given the high concentration of control by a single individual.
• Confirm revenue trends and contract pipeline to assess operational stability beyond balance sheet strength.
• Validate the valuation and impairment assessment of fixed assets, although they are a small portion of total assets.